Effect of Baricitinib on the Pharmacokinetics of Digoxin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2017
At a glance
- Drugs Baricitinib (Primary) ; Digoxin
- Indications Arrhythmias; Diabetic nephropathies; Psoriasis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 26 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 May 2013 New trial record